(VIANEWS) - Western Alliance Bancorporation (WAL), Perion Network Ltd (PERI), Ecolab (ECL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Western Alliance Bancorporation (WAL)
34.5% sales growth and 21.19% return on equity
Western Alliance Bancorporation operates as the bank holding company for Western Alliance Bank that provides various banking products and related services primarily in Arizona, California, and Nevada. It operates in Commercial, Consumer Related, and Corporate & Other segments. The company offers deposit products, including checking, savings, and money market accounts, as well as fixed-rate and fixed maturity certificates of deposit accounts; and treasury management and residential mortgage products and services. It also offers commercial and industrial loan products, such as working capital lines of credit, loans to technology companies, inventory and accounts receivable lines, mortgage warehouse lines, equipment loans and leases, and other commercial loans; commercial real estate loans, which are secured by multi-family residential properties, professional offices, industrial facilities, retail centers, hotels, and other commercial properties; construction and land development loans for single family and multi-family residential projects, industrial/warehouse properties, office buildings, retail centers, medical office facilities, and residential lot developments; and consumer loans. In addition, the company provides other financial services, such as internet banking, wire transfers, electronic bill payment and presentment, lock box services, courier, and cash management services. Further, it holds certain investment securities, municipal and non-profit loans, and leases; invests primarily in low-income housing tax credits and small business investment corporations; and holds certain real estate loans and related securities. The company operates 36 branch locations, as well as loan production offices. Western Alliance Bancorporation was founded in 1994 and is headquartered in Phoenix, Arizona.
Earnings per Share
Western Alliance Bancorporation's trailing twelve-month EPS is $9.43.
PE Ratio
Western Alliance Bancorporation's trailing 12-month price-to-earnings ratio is 7.35. The purchaser of the shares is therefore investing $7.35 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 21.19%.Growth Estimates Quarters
For the current quarter, the company expects to grow by 15.5% and 15% respectively.Dividend Yield
Morningstar, Inc. has stated that the next dividend payment will be on November 16, 2022. The forward dividend rate and forward dividend yield are both 1.44 percent and 2.11%, respectively.
Annual Top and Bottom Value
Western Alliance Bancorporation stock was valued at $69.29 as of 10:22 EST. This is way lower than the 52-week high at $124.93, and much higher than its 52 week low at $54.86.
Revenue growth
The year-over-year revenue growth was 18.5%. We now have 2.32B in the 12 trailing months.
2. Perion Network Ltd (PERI)
12.3% sales growth and 19.23% return on equity
Perion Network Ltd. provides digital advertising solutions to brands, agencies, and publishers in North America, Europe, and internationally. It provides Wildfire, a content monetization platform; search monetization solutions, including website monetization, search mediation, and app monetization; and cross-channel digital advertising software as a service platform. The company also offers supply management platform; demand management platform for campaign planning and design; analytics platform, which provides information and performance insights on the results of campaign investment and other campaign metrics; creative platform to create advertisements; and an AI platform that uses machine learning to bring intelligence to the various phases of campaigns. In addition, it provides an actionable performance monitoring platform to support the various phases of campaign management; an online video player and integrated ad server to upload, manage, and stream video content; content monetization system, which integrates ads within the content layouts at the page level. Further, the company offers a publisher management system that provides analytics and performance optimization tools, as well as reports; search-demand management systems; monetization products that integrate and onboards demand vendors; and AI Systems. Additionally, it provides Intelligent HUB (iHUB), a platform for pulling in signals across various advertising channels and optimizing traffic at scale, and yielding engagement metrics and KPIs; and strategic optimization of relevant traits (SORT), a provisional patent technology that eliminates the need for cookies. The company was formerly known as IncrediMail Ltd. and changed its name to Perion Network Ltd. in November 2011. Perion Network Ltd. was incorporated in 1999 and is headquartered in Holon, Israel.
Earnings per Share
Perion Network Ltd's trailing twelve-month EPS is $1.78.
PE Ratio
Perion Network Ltd's trailing 12-month price-to-earnings ratio is 14.61. The purchaser of the shares is therefore investing $14.61 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 19.23%.3. Ecolab (ECL)
10.3% sales growth and 16.19% return on equity
Ecolab Inc. offers water, hygiene and prevention services and products in the United States as well as internationally. Global Industrial, Global Institutional & Specialty and Global Healthcare & Life Sciences are the segments that make up Ecolab Inc. The company's Global Industrial segment provides water treatment and process solutions, as well as cleaning and sanitizing services for manufacturing, food processing, transport, chemical, metals, mining, power generation and pulp and paper. It also offers water treatment, wastewater treatment, and cleaning and sanitation solutions for the petroleum, refining and petrochemical sectors. Global Institutional & Specialty provides specialized cleaning products for the hospitality, foodservice, lodging, education and retail sectors. The company's Global Healthcare & Life Sciences section offers specialized cleaning products for the pharmaceutical, healthcare and personal care industries. These include infection prevention, surgical solutions and complete cleaning and contamination control under the Ecolab and Microtek brand names. Its Other segment provides pest control services that can detect, remove, and prevent insects such as rodents in food and drink processors, hospitals, education and healthcare facilities and hotels. The segment provides colloidal silicon for polishing and binding applications in aerospace, semiconductor and catalyst component manufacturing as well chemical industries. It also offers products and services to manage the wash process, including premium products, dispensing gear, water management and real-time data management. The company sells products via field sales, corporate account personnel and distributors. It was established in Saint Paul in Minnesota in 1923.
Earnings per Share
Ecolab's trailing 12 month EPS is $-4.53.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 16.19%.Moving Average
Ecolab's value exceeds its $50-day moving mean of $149.00, and is below its $200-day moving mean of $163.14.Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Sep 18, 2022, the estimated forward annual dividend rate is 2.04 and the estimated forward annual dividend yield is 1.33%.
4. Novanta (NOVT)
6.5% sales growth and 13.92% return on equity
Novanta Inc. and its subsidiaries design, manufacture, market, and sell photonics and vision components to original equipment makers in the industrial and medical markets around the world. The company's Photonics division offers photonics solutions including beam delivery and laser scanning, laser scanning, laser marking, laser solid state, lasers, lasers with high speed, lasers that can be used for laser-based industrial processes, as well as products to power optical light engines. These include medical, life-science imaging, laser sequencing and metrology. Vision provides medical-grade technologies such as medical insufflators and pumps and associated disposables. It also offers wireless recorder and video integration technology for operating room integrations. The Precision Motion segment includes optical and inductive encoders as well as precision motors and motion control sub-assemblies. It also offers servo drives and air bearings. It sells products via its direct sales force as well as through resellers and distributors. In May 2016, Novanta Inc. was renamed to GSI Group, Inc. Novanta Inc. was established in 1968. It is located in Bedford, Massachusetts.
Earnings Per Share
As for profitability, Novanta has a trailing twelve months EPS of $2.1.
PE Ratio
Novanta has a trailing twelve months price to earnings ratio of 75.62. Meaning, the purchaser of the share is investing $75.62 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.92%.Yearly Top and Bottom Value
Novanta's stock is valued at $158.81 at 10:27 EST, way under its 52-week high of $177.50 and way higher than its 52-week low of $110.84.
Moving Average
Novanta's worth is way higher than its 50-day moving average of $129.88 and way above its 200-day moving average of $132.47.5. West Pharmaceutical (WST)
5.8% sales growth and 30.76% return on equity
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Earnings Per Share
As for profitability, West Pharmaceutical has a trailing twelve months EPS of $5.57.
PE Ratio
West Pharmaceutical has a trailing twelve months price to earnings ratio of 42.93. Meaning, the purchaser of the share is investing $42.93 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 30.76%.Revenue growth
The year-on-year revenue growth was 6.6%. We now have 2.93B in the 12 trailing months.
Annual Top and Bottom Value
West Pharmaceutical stock was valued at $239.02 as of 10:27 EST. This is way below its 52 week high of $475.00, and far above its 52 week low of $206.19.
6. IDEX Corporation (IEX)
5.1% sales growth and 20.81% return on equity
IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as offers flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries. The HST segment designs, produces, and distributes precision fluidics, rotary lobe pumps, centrifugal and positive displacement pumps, roll compaction and drying systems, pneumatic components and sealing solutions, high performance molded and extruded sealing components, custom mechanical and shaft seals, engineered hygienic mixers and valves, biocompatible medical devices and implantables, air compressors and blowers, optical components and coatings, laboratory and commercial equipment, precision photonic solutions, and precision gear and peristaltic pump technologies. This segment serves food and beverage, pharmaceutical and biopharmaceutical, cosmetics, marine, chemical, wastewater and water treatment, life sciences, research, and defense markets. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, rescue tools, lifting bags, and other components and systems for the fire and rescue industry; engineered stainless steel banding and clamping devices for various industrial and commercial applications; and precision equipment for dispensing, metering, and mixing colorants and paints used in retail and commercial businesses. IDEX Corporation was incorporated in 1987 and is headquartered in Northbrook, Illinois.
Earnings Per Share
As for profitability, IDEX Corporation has a trailing twelve months EPS of $5.09.
PE Ratio
IDEX Corporation has a trailing twelve months price to earnings ratio of 46.96. Meaning, the purchaser of the share is investing $46.96 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.81%.Moving Average
IDEX Corporation's worth is way above its 50-day moving average of $212.04 and way higher than its 200-day moving average of $198.41.Revenue Growth
Year-on-year quarterly revenue growth grew by 15.7%, now sitting on 3.09B for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Oct 12, 2022, the estimated forward annual dividend rate is 2.4 and the estimated forward annual dividend yield is 1.09%.